The Oncology Institute Stock Probability of Future Stock Price Finishing Over 49.85
| TOIIW Stock | USD 0.01 0 20.00% |
Oncology |
Oncology Institute Target Price Odds to finish over 49.85
The tendency of Oncology Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 49.85 or more in 90 days |
| 0.01 | 90 days | 49.85 | close to zero percent |
Based on a normal probability distribution, the odds of Oncology Institute to move over $ 49.85 or more in 90 days from now is close to zero percent (This The Oncology Institute probability density function shows the probability of Oncology Stock to fall within a particular range of prices over 90 days) . Probability of The Oncology Institute price to stay between its current price of $ 0.01 and $ 49.85 at the end of the 90-day period is roughly 97.0 .
Assuming the 90 days horizon The Oncology Institute has a beta of -2.92. This usually implies as returns on its benchmark rise, returns on holding The Oncology Institute are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Oncology Institute is expected to outperform its benchmark. Moreover The Oncology Institute has an alpha of 1.5896, implying that it can generate a 1.59 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Oncology Institute Price Density |
| Price |
Predictive Modules for Oncology Institute
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as The Oncology Institute. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Oncology Institute Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Oncology Institute is not an exception. The market had few large corrections towards the Oncology Institute's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold The Oncology Institute, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Oncology Institute within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 1.59 | |
β | Beta against Dow Jones | -2.92 | |
σ | Overall volatility | 0 | |
Ir | Information ratio | 0.06 |
Oncology Institute Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Oncology Institute for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for The Oncology Institute can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Oncology Institute is way too risky over 90 days horizon | |
| Oncology Institute has some characteristics of a very speculative penny stock | |
| Oncology Institute appears to be risky and price may revert if volatility continues | |
| Oncology Institute has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 324.24 M. Net Loss for the year was (83.07 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| The Oncology Institute has accumulated about 15.17 M in cash with (36.31 M) of positive cash flow from operations. | |
| Latest headline from news.google.com: Oncology institute director Brad Hively acquires 50,000 in stock - Investing.com |
Oncology Institute Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Oncology Stock often depends not only on the future outlook of the current and potential Oncology Institute's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Oncology Institute's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 73.7 M | |
| Cash And Short Term Investments | 82.9 M |
Oncology Institute Technical Analysis
Oncology Institute's future price can be derived by breaking down and analyzing its technical indicators over time. Oncology Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of The Oncology Institute. In general, you should focus on analyzing Oncology Stock price patterns and their correlations with different microeconomic environments and drivers.
Oncology Institute Predictive Forecast Models
Oncology Institute's time-series forecasting models is one of many Oncology Institute's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Oncology Institute's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about The Oncology Institute
Checking the ongoing alerts about Oncology Institute for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for The Oncology Institute help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Oncology Institute is way too risky over 90 days horizon | |
| Oncology Institute has some characteristics of a very speculative penny stock | |
| Oncology Institute appears to be risky and price may revert if volatility continues | |
| Oncology Institute has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 324.24 M. Net Loss for the year was (83.07 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| The Oncology Institute has accumulated about 15.17 M in cash with (36.31 M) of positive cash flow from operations. | |
| Latest headline from news.google.com: Oncology institute director Brad Hively acquires 50,000 in stock - Investing.com |
Additional Tools for Oncology Stock Analysis
When running Oncology Institute's price analysis, check to measure Oncology Institute's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncology Institute is operating at the current time. Most of Oncology Institute's value examination focuses on studying past and present price action to predict the probability of Oncology Institute's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncology Institute's price. Additionally, you may evaluate how the addition of Oncology Institute to your portfolios can decrease your overall portfolio volatility.